Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Atea Pharmaceuticals Inc.

    NASDAQ: AVIR · Real-Time Price · USD
    3.17
    -0.04 (-1.25%)
    At close: Jun 13, 2025, 3:59 PM
    3.29
    3.95%
    After-hours: Jun 13, 2025, 05:22 PM EDT

    Atea Pharmaceuticals Statistics

    Share Statistics

    Atea Pharmaceuticals has 85.58M shares outstanding. The number of shares has increased by 1.55% in one year.

    Shares Outstanding

    n/a
    		 85.58M

    Shares Change (YoY)

    n/a
    		 1.55%

    Shares Change (QoQ)

    n/a
    		 1.26%

    Owned by Institutions (%)

    n/a
    		 66.72%

    Shares Floating

    n/a
    		 69.54M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,656

    FTD / Avg. Volume

    n/a
    		 0.41%

    Short Selling Information

    The latest short interest is 3.06M, so 3.57% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.06M

    Short % of Shares Out

    n/a
    		 3.57%

    Short % of Float

    n/a
    		 4.49%

    Short Ratio (days to cover)

    n/a
    		 7.92

    Valuation Ratios

    The PE ratio is -1.68 and the forward PE ratio is -1.95. Atea Pharmaceuticals's PEG ratio is -0.07.

    PE Ratio

    n/a
    		 -1.68

    Forward PE

    n/a
    		 -1.95

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 7.1

    PB Ratio

    n/a
    		 0.64

    P/FCF Ratio

    n/a
    		 -2.08

    PEG Ratio

    n/a
    		 -0.07
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Atea Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 24.85, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 24.85

    Quick Ratio

    n/a
    		 24.85

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-3,006,875

    Employee Count

    n/a
    		 56

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 925K

    Effective Tax Rate

    n/a
    		 -0.55%

    Stock Price Statistics

    The stock price has increased by -12.19% in the last 52 weeks. The beta is 0.18, so Atea Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.18

    52-Week Price Change

    n/a
    		 -12.19%

    50-Day Moving Average

    n/a
    		 2.91

    200-Day Moving Average

    n/a
    		 3.2

    Relative Strength Index (RSI)

    n/a
    		 58.84

    Average Volume (20 Days)

    n/a
    		 399,163

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -192.95M

    Net Income

    n/a
    		 -168.38M

    EBITDA

    n/a
    		 -167.04M

    EBIT

    n/a
    		 -167.46M

    Earnings Per Share (EPS)

    n/a
    		 -2
    Full Income Statement

    Balance Sheet

    The company has 64.7M in cash and 1.64M in debt, giving a net cash position of 63.05M.

    Cash & Cash Equivalents

    n/a
    		 64.7M

    Total Debt

    n/a
    		 1.64M

    Net Cash

    n/a
    		 63.05M

    Retained Earnings

    n/a
    		 -364.22M

    Total Assets

    n/a
    		 439.96M

    Working Capital

    n/a
    		 411.96M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -135.5M and capital expenditures 0, giving a free cash flow of -135.5M.

    Operating Cash Flow

    n/a
    		 -135.5M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -135.5M

    FCF Per Share

    n/a
    		 -1.61
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    AVIR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for AVIR is $6, which is 89.3% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $6

    Price Target Difference

    n/a
    		 89.3%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 3.86

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist